Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Bedrijfsomschrijving Leid jouw team naar succes, bepaal de controle strategie en controleer de jaarrekeningen voor toonaangevende bedrijven. Bij Deloitte. Vacatureomschrijving opstellen van het dienstverleningsplan voor de klant, samen met de Partners en Managers; identificeren van probleemgebieden en
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
The opportunity: Being part of HSBC in Switzerland, you’ll help evolve and grow our business. The Front Office Customer Due Diligence Advisor is responsible for championing end-to-end CDD activity across onboarding and the client lifecycle, driving
The opportunity: Being part of HSBC in Switzerland, you’ll help evolve and grow our business. The Front Office Customer Due Diligence Advisor is responsible for championing end-to-end CDD activity across onboarding and the client lifecycle, driving
Rockwell Automation is a global technology leader focused on helping the world’s manufacturers be more productive, sustainable, and agile. With more than 28,000 employees who make the world better every day, we know we have something
Parkosecure GmbH est l’un des principaux fournisseurs de solutions modernes de gestion du stationnement en Suisse alémanique. Grâce à des systèmes numériques, à la technologie Free Flow et à des processus clairement structurés, nous créons une
Founded in 1921 and headquartered in Mendrisio (Switzerland), Sinteticas mission is to continuously strive to improve therapies by enhancing its products formulations and usability for the benefit of clinicians and patients. We do so in close
DEINE AUFGABENBEREICHE Du übernimmst die Verantwortung für das Safety Management in unseren internationalen Aufträgen Du erstellst die Sicherheitsnachweise für unsere Fahrzeugmoderniserungen Du übernimmst die Planung und Durchführung der Nachweisführung zusammen mit dem Engineering und anderen Stellen
Stadler bietet vielseitige Möglichkeiten für eine internationale Karriere. Bei Stadler bekommst du die Chance, über dich hinaus zu wachsen, Verantwortung zu übernehmen und grossartige Leistungen im Team zu erbringen. Wir sind auf der Suche nach motivierten
Rockwell Automation is a global technology leader focused on helping the world’s manufacturers be more productive, sustainable, and agile. With more than 28,000 employees who make the world better every day, we know we have something
The opportunity: Being part of HSBC in Switzerland, you’ll help evolve and grow our business. The Front Office Customer Due Diligence Advisor is responsible for championing end-to-end CDD activity across onboarding and the client lifecycle, driving
Einführung in das Unternehmen Wir stellen nicht nur legendäre Uhren her; wir gehen mit der Technologie mit! Die Swatch Group Services Ltd. verfügt über ein IT-Kompetenzzentrum für unsere 16 Marken, das Tony Stark neidisch machen würde.
Rockwell Automation is a global technology leader focused on helping the world’s manufacturers be more productive, sustainable, and agile. With more than 28,000 employees who make the world better every day, we know we have something
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&AQ pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a